Stock AnalizImax Corp. IMAX
Industrial Machinery/Components · data as of November 13, 2026
Imax Corp. (IMAX) is a consumer discretionary company listed in the US with a market value of about $2.7B. In the twelve months to September 30, 2026 it had revenue of $484M and net income of $134M, a net margin of 27.7%.
Its overall Stock Analiz score is 2.6 out of 5 (average). The strongest part is financial health (5/5); the weakest is track record (1/5).
Key numbers: a P/E of 20.9, a price to free cash flow of 18.3, 5-year revenue growth of 25% a year, a 5-year average ROIC of 9%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 55% below the current price.
Score: 2.6 / 5
Checks passed
- P/E below 25
- P/FCF below 20
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- 3-year free cash flow growth above 10% a year
- 5-year revenue growth above 8% a year
- More cash than debt, or low debt to equity
Checks not passed
- P/E below the industry median
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Strong R&D investment or growth above 20%
- 5-year EPS growth above 10% a year
- 5-year average ROIC above 12%
- Profitable 5 years in a row
- ROE above 15%
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $484M | $410M | $352M | $375M | $301M | $255M | $137M | $396M | $374M | $381M | $377M |
| Net income | $134M | $35M | $26M | $25M | -$23M | -$22M | -$144M | $47M | $23M | $2M | $29M |
| Free cash flow | $146M | $119M | $62M | $52M | $9M | $2M | -$24M | $83M | $97M | $61M | $63M |
| EPS (diluted) | $2.31 | $0.63 | $0.48 | $0.46 | $-0.40 | $-0.38 | $-2.43 | $0.76 | $0.00 | $0.00 | $0.00 |
| Net margin | 27.7% | 8.5% | 7.4% | 6.8% | -7.6% | -8.8% | -104.9% | 11.8% | 6.1% | 0.6% | 7.6% |
| ROIC | — | 17.4% | 12.2% | 12.6% | -1.4% | 2.3% | -13.4% | 10.3% | 6.2% | 4.5% | 7.2% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 12 analysts is $60.00, 24% above the current price; targets range from $49.00 to $65.00; the consensus rating is “Buy”; expected EPS is $2.85 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Imax’s P/E ratio?
About 20.9, based on the last twelve months of diluted earnings per share (forward P/E about 25.8).
Is Imax stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 55% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Imax pay a dividend?
Not currently.
Is Imax a good stock to buy?
We do not give buy or sell advice. Imax scores 2.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.